Published in Clin Exp Immunol on April 01, 1970
Natural thymocytotoxic autoantibody and reactive antigen in New Zealand black and other mice. Proc Natl Acad Sci U S A (1971) 3.50
Studies on thymus products. IV. Absence of serum 'thymic activity' in adult NZB and (NZB x NZW) F1 mice. Clin Exp Immunol (1973) 1.93
A defect of B-lymphocyte transport of aggregated HGG into germinal centres in NZB and NZB x NZW F 1 hybrid mice. Clin Exp Immunol (1972) 1.38
Natural cytotoxic autoantibody against thymocytes in NZB mice. Clin Exp Immunol (1972) 1.34
Changes in lymphoid populations of ageing CBA and NZB mice. Clin Exp Immunol (1971) 1.31
Progressive loss in vitro of cellular immunity with ageing in strains of mice susceptible to autoimmune disease. Clin Exp Immunol (1971) 1.28
Thymosin corrects the abnormal DNA synthetic response of NZB mouse thymocytes. Proc Natl Acad Sci U S A (1974) 1.19
Evidence for the genetic control of antibody affinity from breeding studies with inbred mouse strains producing high and low affinity antibody. Immunology (1976) 1.15
Age-decrease of cells sensitive to an autoantibody-specific for thymocytes and thymus-dependent lymphocytes in NZB mice. Clin Exp Immunol (1972) 1.14
The age related responses of New Zealand mice to a murine sarcoma virus. Clin Exp Immunol (1971) 1.11
T and B lymphocytes in New Zealand black mice. An analysis of the theta, TL and MBLA markers. Clin Exp Immunol (1972) 1.03
Independent appearance of anti-thymocyte and anti-RNA antibodies in NZB/NZW F1 mice. Immunology (1975) 0.88
Alteration in DNA synthetic response of thymocytes from NZB mice of different ages. Proc Natl Acad Sci U S A (1973) 0.85
Immunopathology of New Zealand Black mice treated with antilymphocyte globulin. Immunology (1971) 0.84
The immunology and pathology of NZB mice. Adv Immunol (1968) 9.04
Thymus and antigen-reactive cells. Transplant Rev (1969) 8.84
The thymus and the cellular basis of immunity. Transplant Rev (1969) 7.23
Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms. J Natl Cancer Inst (1954) 6.30
Immunopathology of NZB/BL mice. V. Viruslike (filtrable) agent separable from lymphoma cells and identifiable by electron microscopy. J Exp Med (1966) 4.19
Further implication of murine leukemia-like virs in the disorders of NZB mice. J Exp Med (1969) 3.87
RECIRCULATION OF LYMPHOCYTES. Ann N Y Acad Sci (1964) 3.50
Immunopathology of New Zealand black (NZB) mice. Transplantation (1965) 3.06
Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology (1968) 2.98
IN-VITRO STUDIES OF LYMPHOCYTES FROM PATIENTS WITH SARCOIDOSIS AND LYMPHOPROLIFERATIVE DISEASES. Lancet (1964) 2.86
The appearance of immunological competence at an early age in New Zealand black mice. Clin Exp Immunol (1968) 2.73
Autoimmune disease in NZB-Bl mice. II. Autoimmunity and malignant lymphoma. Blood (1966) 2.51
Deficient immunologic functions of NZB mice. Proc Soc Exp Biol Med (1968) 2.41
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Effect of thymectomy in adult mice on immunological responsiveness. Nature (1965) 1.91
RADIOAUTOGRAPHIC STUDIES OF BONE MARROW LYMPHOCYTES IN VIVO AND IN DIFFUSION CHAMBER CULTURES. Blood (1964) 1.79
The immune response in NZB and NZB x C3H F1-hybrid mice as measured by the haemolysin plaque technique. Int Arch Allergy Appl Immunol (1966) 1.55
Light and electron microscope studies of organs and tissues of the New Zealand Black (NZB/BL) strain mice with lymphoid leukemia and autoimmune disease. Cancer Res (1967) 1.54
Malignant changes in New Zealand black mice. Clin Exp Immunol (1967) 1.52
Particles resembling murine leukaemia virus in New Zealand black mice. Clin Exp Immunol (1968) 1.50
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Syngeneic splenomegaly in NZB and BALB-c mice. Transplantation (1969) 1.30
The immune response in NZBxNZW F1 hybrid mice. Clin Exp Immunol (1969) 1.30
EFFECT OF X-RADIATION ON DNA METABOLISM IN VARIOUS TISSUES OF THE RAT. V. DNA METABOLISM IN REGENERATING THYMUS. Radiat Res (1963) 1.27
Immunodepression by viruses. Antibiot Chemother (1969) 1.25
Autoimmune reactions and malignant changes in germ-free New Zealand Black mice. Clin Exp Immunol (1969) 1.23
Thymus-dependent lymphocytes: destruction by lymphocytic choriomeningitis virus. Science (1969) 1.11
The effect of heterologous anti-lymphocyte seerum on mouse hemopoietic stem cells. J Exp Med (1968) 1.07
Naturally occurring haemagglutinins in the New Zealand black mouse. Clin Exp Immunol (1969) 0.89
The transformed cell in thymus-PHA cultures: blood or tissue origin? Blood (1968) 0.84
The role of the thymus in development of lympho-hemopoietic tissues. The effect ofthymectomy on development of blood cells, bone-marrow, spleen, and lymph nodes. Anat Rec (1969) 0.81
Secondary antibody response of overtly autoimmune NZB mice. Immunology (1969) 0.78
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33
Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29
Effect of anti-lymphocyte globulin on kidney disease in (N.Z.B. x N.Z.W.) F 1 mice. Lancet (1966) 1.27
Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol (1980) 1.20
The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis. J Infect (1983) 1.18
A new manifestation of infection with Epstein-Barr virus. Br Med J (1978) 1.14
Defective B cell function in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.13
Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) (2001) 1.11
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G. J Immunol (1967) 1.08
Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis (1984) 1.07
Lymphokine-activated killer cell activity in rheumatoid arthritis. Clin Exp Immunol (1987) 1.05
Inactivation of influenza virus by human lymphocytes. Clin Exp Immunol (1974) 1.04
Herpes simplex virus depresses antibody production by affecting T-cell function. Nature (1980) 1.04
Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet (1984) 1.02
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol (1984) 1.01
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. i. Failure of the virus to grow in cultured lymphocytes. Ann Rheum Dis (1979) 1.01
Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.01
Replication or inactivation of different viruses by human lymphocyte preparations. Infect Immun (1974) 0.99
Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol (1987) 0.97
Self-tolerance and autoimmunity. Br Med Bull (1976) 0.97
Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. Ann Rheum Dis (1982) 0.97
Defective repair of 0(6)-methylguanine in autoimmune diseases. Lancet (1982) 0.96
Immunodeficiency and general medicine. Br Med J (1980) 0.95
Pregnancy and immunological disorders. Br Med J (Clin Res Ed) (1982) 0.94
The viral theory of connective tissue diseases: a review. Med Biol (1975) 0.93
Measruement of immunological function in man: interaction between virus and human leukocytes. Proc R Soc Med (1974) 0.93
The rheumatoid synovial membrane participates in systemic anti-viral immune responses. Clin Exp Immunol (1985) 0.93
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. ii. Mechanisms of non-permissiveness. Ann Rheum Dis (1979) 0.93
Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies. Clin Exp Immunol (1983) 0.93
A search for retrovirus infection in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis (1988) 0.90
2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Ann Rheum Dis (1986) 0.89
Normal induction and maintenance of tolerance in (NZBxNZW) F1 mice. Clin Exp Immunol (1969) 0.89
Review: method of separating human blood lymphoid cell populations. J Immunol Methods (1973) 0.89
Autoimmune disease in inbred mice. Clin Exp Immunol (1967) 0.88
Improved graft survival after treatment with Bordetella and anti-lymphocyte serum. Nature (1969) 0.88
Spontaneous production of B cell growth factors by SLE lymphocytes. Clin Exp Immunol (1987) 0.87
Intensive immunosuppression in intractable rheumatoid arthritis. Br J Rheumatol (1986) 0.87
The treatment of connective tissue diseases with antilymphocyte globulin. Postgrad Med J (1976) 0.86
Nature and diagnosis of food allergy. Proc Nutr Soc (1979) 0.86
Cytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with systemic lupus erythematosus. Clin Exp Immunol (1991) 0.86
Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol (1992) 0.85
Malignancies induced by chlorambucil. Cancer Treat Rev (1984) 0.85
Selective immunosuppressive effects of measles virus infection. Clin Exp Immunol (1982) 0.85
Lymphocyte function and virus infections. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.85
Immunopathology of New Zealand Black mice treated with antilymphocyte globulin. Immunology (1971) 0.84
Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial. Br J Rheumatol (1988) 0.84
Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody. Clin Exp Immunol (1970) 0.83
Increased sensitivity of lymphocytes from patients with systemic autoimmune diseases to DNA alkylation by the methylating carcinogen N-methyl-N-nitrosourea. Ann Rheum Dis (1988) 0.83
Immunoregulatory effects of interferon-alpha. I. Interferon-alpha inhibits in vitro antibody synthesis by normal human lymphocytes. Clin Exp Immunol (1985) 0.82
Immunity and depression. Br Med J (Clin Res Ed) (1986) 0.82
Endothelial prostacyclin release in systemic lupus erythematosus. Thromb Haemost (1989) 0.82
Retroperitoneal fibrosis and polyarteritis nodosa successfully treated by intensive immunosuppression. J R Soc Med (1980) 0.81
Induction of antibody synthesis in cultures of human lymphoid cells. Int Arch Allergy Appl Immunol (1973) 0.81
Inflammatory disorders of muscle. Aetiology. Clin Rheum Dis (1984) 0.80
Lymphocyte responses in juvenile chronic arthritis and Behçet's disease--cell number requirements and effects of glucocorticosteroid therapy. Clin Exp Immunol (1982) 0.80
Scleroderma treated with immunosuppressive drugs. Br J Dermatol (1979) 0.79
Rheumatoid arthritis--a virus disease? J Clin Pathol Suppl (R Coll Pathol) (1978) 0.79
Rheumatoid arthritis in a patient with primary hypogammaglobulinaemia. Br J Rheumatol (1993) 0.79
Rheumatoid arthritis. Aetiology. Br Med J (1970) 0.79
Sister-chromatid exchange frequencies in fibroblasts and lymphocytes of patients with systemic lupus erythematosus. Mutat Res (1987) 0.78
Sensitivity of lymphocytes from patients with systemic lupus erythematosus to the induction of sister chromatid exchanges by alkylating agents and bromodeoxyuridine. Ann Rheum Dis (1987) 0.77
A viral aetiology for juvenile chronic arthritis? Br J Rheumatol (1988) 0.77
Lymphocyte function and disease. Br Med J (1978) 0.77
A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) production. Clin Exp Immunol (1995) 0.77
Cyclophosphamide induces more chromosome damage than chlorambucil in patients with connective tissue diseases. Q J Med (1986) 0.77
Cryoglobulins and the immunopathological manifestations of autoimmune disease. Clin Exp Immunol (1992) 0.76
Studies in chronic lymphocytic leukaemia II. Lymphocyte markers, cellular and humoral immunity and the effect of treatment. Postgrad Med J (1980) 0.75
Infection with Epstein-Barr virus. Br Med J (1979) 0.75
Anti-thymocyte globulin in scleroderma. Rheumatology (Oxford) (2001) 0.75
Sister-chromatid exchange frequencies in lymphocytes of controls and patients with connective tissue diseases. Mutat Res (1986) 0.75
Fate of herpes simplex virus in lymphocytes from blood and joint effusions of systemic and pauciarticular juvenile chronic arthritis. Ann Rheum Dis (1983) 0.75
Response of the thymus and immunologically induced lymphopenia. Proc Soc Exp Biol Med (1967) 0.75
Graft-versus-host disease. Br Med J (Clin Res Ed) (1982) 0.75
Immunoregulatory effects of alpha-interferon. Effects on in-vitro antibody synthesis by lymphocytes from patients with rheumatoid arthritis. Ann Rheum Dis (1985) 0.75
AIDS and CFS/ME. Clin Med (2003) 0.75
Renal disease in (NZB x NZW) F1 mice treated with antilymphocytic antibody. II. Effects of restoration with isogeneic, allogeneic, and xenogeneic lymphoid cells. Clin Exp Immunol (1970) 0.75